1. FC 123: Baseline Characteristics of the Flow Trial Population: Kidney Outcomes Trial With Once-Weekly Semaglutide in People With Type 2 Diabetes and Chronic Kidney Disease. (3rd May 2022) Authors: Perkovic, Vlado; Baeres, Florian; Bakris, George; Bosch-Traberg, Heidrun; Idorn, Thomas; Mahaffey, Kenneth; Mann, Johannes; Mersebach, Henriette; Rossing, Peter; Tuttle, Katherine; Pratley, Richard Journal: Nephrology dialysis transplantation Issue: Volume 37(2022)Supplement 3 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. LEADER 7: cardiovascular risk profiles of US and European participants in the LEADER diabetes trial differ. Issue 1 (December 2016) Authors: Rutten, Guy; Tack, Cees; Pieber, Thomas; Comlekci, Abdurrahman; Ørsted, David; Baeres, Florian; Marso, Steven; Buse, John Journal: Diabetology & metabolic syndrome Issue: Volume 8:Issue 1(2016) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗